Management tracks

RNA therapeutics company Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) said SVP and CBO David-Alexandre Gros will resign for personal reasons, effective Jan. 6. The company is searching for a replacement. Alnylam also promoted SVP of Clinical Development Pushkal Garg to CMO from SVP of clinical development.

Gilead Sciences Inc. (NASDAQ:GILD) hired Alessandro Riva as SVP of hematology and oncology therapeutic area head. Riva was head of global oncology development at the Novartis Oncology unit of Novartis AG (NYSE:NVS; SIX:NOVN). ...